Please login to the form below

Not currently logged in
Email:
Password:

INC Research appoints Robert Ryan

Joins CRO's new Strategic Advisory Services unit

INC Research Robert RyanINC Research has appointed Robert Ryan as vice president of regulatory strategy, consulting and submissions within its new Strategic Advisory Services unit.

He joins the contract research organisation (CRO) from CNS and pain-focused pharmaceutical development company Levare, where he was chairman of the board.

Prior to this Ryan spent time with other CROs and biopharmaceutical companies, including Quintiles, PPD, Celtic Therapeutics and Schwarz Pharma.

In his new role at INC Ryan will be tasked with positioning INC's new Strategic Advisory Services as a market leader in regulatory consulting and submissions offerings.

Tim Dietlin, senior vice president of global consulting and strategic alliances, said: "Robert brings a unique blend of strategic leadership skills and international regulatory expertise that speaks to biopharmaceutical companies looking for guidance along the entire continuum of the drug development life cycle.

"Our Regulatory Consulting and Submissions team has a long history of exceptional work, and we look forward to continuing this track record under Robert's leadership."

10th December 2012

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Redbow Consulting Group

Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...

Latest intelligence

Ask the writers: Transitioning from academia to medical writing
Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
Strategic launch planning: familiar framework, new mindset
By James Aird...
Guide
How to embrace behavioural science principles in healthcare MR...